500672 — Novartis India Balance Sheet
0.000.00%
Last trade - 00:00- IN₹19.58bn
- IN₹13.66bn
- IN₹3.35bn
- 82
- 35
- 30
- 48
Annual balance sheet for Novartis India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,804 | 4,974 | 5,163 | 5,544 | 5,850 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,623 | 1,581 | 1,276 | 591 | 648 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,121 | 7,231 | 7,078 | 6,773 | 6,993 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 763 | 639 | 237 | 193 | 69.4 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,776 | 10,023 | 9,576 | 9,829 | 9,249 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,328 | 1,590 | 2,164 | 1,595 | 1,572 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,569 | 2,911 | 2,659 | 2,073 | 1,801 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Total Equity | 7,207 | 7,112 | 6,917 | 7,757 | 7,448 |
| Total Liabilities & Shareholders' Equity | 10,776 | 10,023 | 9,576 | 9,829 | 9,249 |
| Total Common Shares Outstanding |